Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.27−0.01 (-2.92%)
Close on Nov 12, 2026Market cap $1.69MP/E –Yield –
Co-Diagnostics cash
Cash and short-term investments held at the end of each period.
Co-Diagnostics's cash was $714.80K at Sep 30, 2026. For fiscal 2025 it was $11.88M, down 60.0% from the year before. Over ten years it grew 79.7% a year on average. The highest annual figure on record is $89.86M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.88M | -60.0% |
| FY2024 | Dec 31, 2024 | $29.75M | -49.2% |
| FY2023 | Dec 31, 2023 | $58.55M | -28.0% |
| FY2022 | Dec 31, 2022 | $81.26M | -9.6% |
| FY2021 | Dec 31, 2021 | $89.86M | +89.9% |
| FY2020 | Dec 31, 2020 | $47.31M | +5197.3% |
| FY2019 | Dec 31, 2019 | $893.14K | -6.0% |
| FY2018 | Dec 31, 2018 | $950.24K | -73.1% |
| FY2017 | Dec 31, 2017 | $3.53M | +253.9% |
| FY2016 | Dec 31, 2016 | $998.74K | +2854.4% |
| FY2015 | Dec 31, 2015 | $33.81K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $714.80K | -93.8% |
| Q2 FY2026 | Jun 30, 2026 | $3.65M | -72.7% |
| Q1 FY2026 | Mar 31, 2026 | $8.23M | -61.7% |
| Q4 FY2025 | Dec 31, 2025 | $11.88M | -60.0% |
| Q3 FY2025 | Sep 30, 2025 | $11.44M | -69.6% |
| Q2 FY2025 | Jun 30, 2025 | $13.36M | -70.2% |
| Q1 FY2025 | Mar 31, 2025 | $21.48M | -57.0% |
| Q4 FY2024 | Dec 31, 2024 | $29.75M | -49.2% |
| Q3 FY2024 | Sep 30, 2024 | $37.66M | -40.6% |
| Q2 FY2024 | Jun 30, 2024 | $44.88M | -35.1% |
| Q1 FY2024 | Mar 31, 2024 | $49.96M | -33.6% |
| Q4 FY2023 | Dec 31, 2023 | $58.55M | -28.0% |
| Q3 FY2023 | Sep 30, 2023 | $63.43M | -26.7% |
| Q2 FY2023 | Jun 30, 2023 | $69.14M | -28.0% |
| Q1 FY2023 | Mar 31, 2023 | $75.28M | -22.7% |
| Q4 FY2022 | Dec 31, 2022 | $81.26M | -9.6% |
| Q3 FY2022 | Sep 30, 2022 | $86.49M | +3.1% |
| Q2 FY2022 | Jun 30, 2022 | $96.00M | +32.6% |
| Q1 FY2022 | Mar 31, 2022 | $97.42M | +62.1% |
| Q4 FY2021 | Dec 31, 2021 | $89.86M | +89.9% |
| Q3 FY2021 | Sep 30, 2021 | $83.91M | +207.6% |
| Q2 FY2021 | Jun 30, 2021 | $72.38M | +290.2% |
| Q1 FY2021 | Mar 31, 2021 | $60.09M | +246.0% |
| Q4 FY2020 | Dec 31, 2020 | $47.31M | +5197.3% |
| Q3 FY2020 | Sep 30, 2020 | $27.28M | +972.3% |
| Q2 FY2020 | Jun 30, 2020 | $18.55M | +381.1% |
| Q1 FY2020 | Mar 31, 2020 | $17.37M | +220.9% |
| Q4 FY2019 | Dec 31, 2019 | $893.14K | -6.0% |
| Q3 FY2019 | Sep 30, 2019 | $2.54M | +16.9% |
| Q2 FY2019 | Jun 30, 2019 | $3.86M | +152.3% |
| Q1 FY2019 | Mar 31, 2019 | $5.41M | +113.0% |
| Q4 FY2018 | Dec 31, 2018 | $950.24K | -73.1% |
| Q3 FY2018 | Sep 30, 2018 | $2.18M | -52.9% |
| Q2 FY2018 | Jun 30, 2018 | $1.53M | +1208.8% |
| Q1 FY2018 | Mar 31, 2018 | $2.54M | +411.9% |
| Q4 FY2017 | Dec 31, 2017 | $3.53M | +253.9% |
| Q3 FY2017 | Sep 30, 2017 | $4.63M | – |
| Q2 FY2017 | Jun 30, 2017 | $116.77K | – |
| Q1 FY2017 | Mar 31, 2017 | $496.46K | – |
| Q4 FY2016 | Dec 31, 2016 | $998.74K | – |
See a number that looks wrong?